Genetics  	Genetics  	 NNP	O
of  	of  	 IN	O
ankylosing  	ankylosing  	 JJ	B-NP
spondylitis  	spondylitis  	 NN	I-NP
and  	and  	 CC	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis 	arthritis 	 NN	I-NP
:  	:  	 :	O
where  	where  	 WRB	O
are  	are  	 VBP	O
we  	we  	 PRP	O
at  	at  	 IN	O
currently 	currently 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
how  	how  	 WRB	O
do  	do  	 VBP	O
they  	they  	 PRP	O
compare 	compare 	 VBP	O
?  	?  	 .	O
Both  	Both  	 DT	O
ankylosing  	ankylosing  	 JJ	B-NP
spondylitis  	spondylitis  	 NNS	I-NP
( 	( 	 -LRB-	O
AS 	AS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
( 	( 	 -LRB-	O
RA 	RA 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
common 	common 	 JJ	O
,  	,  	 ,	O
highly  	highly  	 RB	O
heritable  	heritable  	 JJ	O
conditions 	conditions 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	O
which  	which  	 WDT	O
are  	are  	 VBP	O
incompletely  	incompletely  	 VBN	O
understood 	understood 	 VBN	O
.  	.  	 .	O
Gene-mapping  	Gene-mapping  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
conditions  	conditions  	 NNS	O
have  	have  	 VBP	O
over  	over  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
couple  	couple  	 NN	O
of  	of  	 IN	O
years  	years  	 NNS	O
made  	made  	 VBD	O
major  	major  	 JJ	O
breakthroughs  	breakthroughs  	 NNS	B-NP
in  	in  	 IN	O
identifying  	identifying  	 VBG	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
by  	by  	 IN	O
which  	which  	 WDT	O
these  	these  	 DT	O
diseases  	diseases  	 NNS	O
occur 	occur 	 VBP	O
.  	.  	 .	O
Considering  	Considering  	 VBG	B-NP
RA 	RA 	 NNP	I-NP
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
an  	an  	 DT	O
over-representation  	over-representation  	 JJ	B-NP
of  	of  	 IN	O
genes  	genes  	 NNS	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
TNF  	TNF  	 NNP	B-NP
signalling  	signalling  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
NFKappaB  	NFKappaB  	 JJ	B-NP
pathway  	pathway  	 NN	I-NP
that  	that  	 WDT	O
have  	have  	 VBP	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
influence  	influence  	 VB	O
the  	the  	 DT	O
disease  	disease  	 NN	B-NP
risk 	risk 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
also  	also  	 RB	O
considerable  	considerable  	 JJ	O
sharing  	sharing  	 NN	O
of  	of  	 IN	O
susceptibility  	susceptibility  	 JJ	B-NP
genes  	genes  	 NNS	I-NP
between  	between  	 IN	O
RA  	RA  	 NNP	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
autoimmune  	autoimmune  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
systemic  	systemic  	 JJ	B-NP
lupus  	lupus  	 JJ	I-NP
erythematosus 	erythematosus 	 NN	I-NP
,  	,  	 ,	O
type  	type  	 NN	O
1  	1  	 CD	O
diabetes 	diabetes 	 NN	O
,  	,  	 ,	O
autoimmune  	autoimmune  	 JJ	B-NP
thyroid  	thyroid  	 JJ	I-NP
disease  	disease  	 NN	I-NP
and  	and  	 CC	O
celiac  	celiac  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
thus  	thus  	 RB	O
far  	far  	 RB	O
little  	little  	 JJ	O
overlap  	overlap  	 NN	O
with  	with  	 IN	O
AS 	AS 	 NNP	O
.  	.  	 .	O
In  	In  	 IN	O
AS 	AS 	 NNP	O
,  	,  	 ,	O
genes  	genes  	 NNS	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
IL12 	IL12 	 CD	B-NP
/ 	/ 	 CD	O
IL23 	IL23 	 CD	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
endoplasmic  	endoplasmic  	 JJ	B-NP
reticulum  	reticulum  	 JJ	I-NP
peptide  	peptide  	 JJ	I-NP
presentation 	presentation 	 NN	I-NP
,  	,  	 ,	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified 	identified 	 VBN	O
,  	,  	 ,	O
but  	but  	 CC	O
a  	a  	 DT	O
full  	full  	 JJ	O
genomewide  	genomewide  	 JJ	B-NP
association  	association  	 NN	I-NP
study  	study  	 NN	I-NP
has  	has  	 VBZ	O
not  	not  	 RB	O
yet  	yet  	 RB	O
been  	been  	 VBN	O
reported 	reported 	 VBN	O
.  	.  	 .	O
